Feed / Theme
Confirmed

Healthcare Diagnostics & Research · DBRG

49 names are moving together; 63% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
VCTRVictory Capital Holdings, Inc.Financial Services-0.3%Group member
ADPTAdaptive Biotechnologies CorporHealthcare-0.3%Group member
WWayfair Inc.Consumer Cyclical-3.1%Group member
COFCapital One Financial CorporatiFinancial Services+0.8%Group member
NEUNewMarket CorpBasic Materials-0.5%Group member
WATWaters CorporationHealthcare-0.9%Group member
EDHLEverbright Digital Holding LimiCommunication Services-9.1%Group member
DBRGDigitalBridge Group, Inc.Financial Services-0.4%Most structurally connected
VCYTVeracyte, Inc.Healthcare+0.9%Group member
MGYMagnolia Oil & Gas CorporationEnergy+3.6%Group member
CODXCo-Diagnostics, Inc.Healthcare+0.4%Group member
UANCVR Partners, LPBasic Materials+1.4%Group member
CFCF Industries Holdings, Inc.Basic Materials+3.5%Group member
CVLGCovenant Logistics Group, Inc.Industrials+1.0%Group member
MRTNMarten Transport, Ltd.Industrials+1.8%Group member
EDITEditas Medicine, Inc.Healthcare-2.9%Group member
BAMBrookfield Asset Management IncFinancial Services-0.2%Group member
UAUnder Armour, Inc.Consumer Cyclical-0.1%Group member
VACMarriott Vacations Worldwide CoConsumer Cyclical-0.8%Group member
MNROMonro, Inc.Consumer Cyclical-1.6%Group member
WWWWolverine World Wide, Inc.Consumer Cyclical+1.8%Group member
COLMColumbia Sportswear CompanyConsumer Cyclical+1.2%Group member
UAAUnder Armour, Inc.Consumer Cyclical-0.5%Group member
MOBXMobix Labs, Inc.Technology+1.6%Group member

Why we believe this

Cohort

49 names

Participation

63% this session

Observed history

1 daily builds

Filing coverage

44/49 members

credit / rates affecting interest expense

The increase reflects $1.9 million of interest expense in 2025 on a fund-level debt prior to its deconsolidation in the fourth quarter of 2025, partially offset by the full exchange/redemption of the remaining 5.75% exchangeable senior notes in April 2024 ($0.4 million) and lower unused fees following a reduction in the VFN borrowing capacity in June 2025 ($0.4 million).

DBRG 10-K

demand / volume affecting revenue

Cumulative catch-up adjustments on our longer-term contracts for changes in estimates were as follows: Three Months Ended (in thousands) November 29, 2025 November 30, 2024 Gross favorable adjustments $ 10,763 $ 9,739 Gross unfavorable adjustments (6,787) (3,938) Net adjustments $ 3,976 $ 5,801 Nine Months Ended (in thousands) November 29, 2025 November 30, 2024 Gross favorable adjustments $ 25,510 $ 20,111 Gross unfavorable adjustments (20,735) (7,206) Net adjustments $ 4,775 $ 12,905 29 Table of Contents Architectural Glass Comparison of Third Quarter Fiscal 2026 to Third Quarter Fiscal 2025 • Net sales were $70.9 million, compared to $70.2 million, primarily due to increased volume and favorable mix, partially offset by lower price driven by lower end-market demand.

APOG 10-Q

restructuring affecting expense

ept percentages) 2025 2024 $ % 2025 2024 Impairment of long-lived assets $ — $ 7,205 $ (7,205 ) (100)% 0 % 17 % The $7.2 million decrease in impairment of long-lived assets expenses was attributable to the impairment of certain long-lived assets and our decision to vacate certain leased space as a result of various restructuring activities in 2024.

ADPT 10-Q

Healthcare Diagnostics & Research can stay leader-led if BAM and the next software names fail to join while DBRG keeps moving.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.